Skip to main content
. 2019 May 24;20(10):2560. doi: 10.3390/ijms20102560

Table 1.

List of endocrine adverse events and recommendations.

Hypophysitis Hypothyroidism Hyperthyroidism Adrenalitis
Grade 1 Clinical symptoms
  • ✓ Asymptomatic or mild symptoms

  • ✓ Asymptomatic or mild symptoms

  • ✓ Absence of symptoms

  • ✓ Absence of symptoms

Clinical management strategies
  • ✓ Intervention not indicated

  • ✓ Intervention not indicated

  • ✓ Intervention not indicated

  • ✓ Intervention not indicated

Grade 2 Clinical symptoms
  • ✓ Mild symptoms such as headache, mood changes and fatigue

  • ✓ Depending on age, mild impairment of the Instrumental Activities of Daily Living

  • ✓ Symptomatic

  • ✓ Symptomatic

  • ✓ Moderate symptoms

Clinical management strategies
  • ✓ Minimal, local or noninvasive intervention indicated

  • ✓ Mild impairment of the Instrumental Activities of Daily Living

  • ✓ Thyroid replacement indicated

  • ✓ It’s recommended thyroid suppression therapy

  • ✓ Limiting instrumental ADL

  • ✓ Medical intervention indicated

Grade 3 Clinical symptoms
  • ✓ The disability can limit self care

  • ✓ Severe or medically significant but not immediately life-threatening

  • ✓ Self care limitation that affects the Activities of Daily Living

  • ✓ Severe symptoms

  • ✓ Self care limitation that affects the Activities of Daily Living

  • ✓ Severe symptoms

  • ✓ Severe symptoms

Clinical management strategies
  • ✓ Hospitalization or prolongation of existing hospitalization indicated

  • ✓ Hospitalization recommended

  • ✓ Hospitalization recommended

  • ✓ Hospitalization recommended

Grade 4 Clinical symptoms
  • ✓ Life-threatening consequences

  • ✓ Life-threatening consequences

  • ✓ Life-threatening consequences

  • ✓ Life-threatening consequences

Clinical management strategies
  • ✓ Urgent intervention recommended

  • ✓ Urgent intervention recommended

  • ✓ Urgent intervention recommended

  • ✓ Urgent intervention recommended

Grade 5
  • ✓ Death

  • ✓ Death

  • ✓ Death

  • ✓ Death

The National Cancer Institute has recommended that adverse events on patients with cancer chemotherapy be graded as per the Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0.